Combined synopsis and solicitation
Adult Vaccines 2024
75D301-24-R-72943
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Pharmaceutical Preparation Manufacturing.
Awarded
$918,000.00 obligated so far on USAspending
Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities
This one was awarded in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 4 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 10 daysNov 12
Description
As published on SAM.gov.
UPDATE 3/29/2024: The answers to vendor questions have been uploaded to this posting. The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. See attached RFP for details.
Hepatitis A Adult Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 1,000,000 doses Minimum: 100 doses Hepatitis B Adult Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 750,000 doses Minimum: 100 doses Hepatitis A & B Combination Adult Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $1.50 per dose Maximum: 250,000 doses Minimum: 100 doses Herpes Zoster Adult Vaccine: Min. Shelf Life 12 months Fed.
Excise Tax N/A Maximum: 500,000 doses Minimum: 100 doses Human Papillomavirus (HPV9)
Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 300,000 doses Minimum: 100 doses E-IPV Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 500,000 doses Minimum: 100 doses Measles, Mumps, and Rubella Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $2.25 per dose Maximum: 250,000 doses Minimum: 100 doses Meningococcal Conjugate-Serogroup B Meningococcal Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $1.50 per dose Maximum: 200,000 doses Minimum: 100 doses Mpox Vaccine: Min. Shelf Life 12 months Fed.
Excise Tax TBD Maximum: 500,000 doses Minimum: 100 doses Serogroup B Meningococcal Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 200,000 doses Minimum: 100 doses Meningococcal Conjugate (Groups A, C, Y & W)
Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 200,000 doses Minimum: 100 doses Pneumococcal Conjugate (PCV)
Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 500,000 doses Minimum: 100 doses Pneumococcal Polysaccharide Vaccine: Min. Shelf Life 12 months Fed.
Excise Tax N/A Maximum: 500,000 doses Minimum: 100 doses Tetanus and Diptheria Toxoids Vaccine for Adults: Min. Shelf Life 12 months Fed. Excise Tax $1.50 per dose Maximum: 100,000 doses Minimum: 100 doses Tetanus, Reduced Diptheria Toxoid & Acellular Pertusis (TdaP)
Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $2.25 per dose Maximum: 850,000 doses Minimum: 100 doses Varicella Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 150,000 doses Minimum: 10 doses
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Bavarian Nordic, Inc.
- UEI
- LA6TFGKSSFC1
- CAGE
- 7V2J4
- Vendor location
- Durham, NC
- Contract
- 75D30124D19078
- Obligated
- $918,000.00, potential $99,015,000
- Actions
- 6 between June 27, 2024 and November 24, 2025
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
- Recipient
- Dynavax Technologies Corporation
- UEI
- JA7GSG397PL1
- CAGE
- 4BYD4
- Vendor location
- Emeryville, CA
- Contract
- 75D30124D19079
- Obligated
- $3,923,889.30, potential $58,455,000
- Actions
- 6 between June 27, 2024 and December 4, 2025
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
- Recipient
- Glaxosmithkline, LLC
- UEI
- FRHTPHMZMX47
- CAGE
- 667E9
- Vendor location
- Durham, NC
- Contract
- 75D30124D19080
- Obligated
- $13,152,248.21, potential $154,336,160
- Actions
- 7 between June 27, 2024 and November 24, 2025
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
- Recipient
- Merck Sharp & Dohme LLC
- UEI
- FCFDA78HKKG2
- CAGE
- 6B2S4
- Vendor location
- Rahway, NJ
- Contract
- 75D30124D19081
- Obligated
- $13,253,480.77, potential $69,520,654
- Actions
- 8 between June 27, 2024 and December 5, 2025
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
- Recipient
- Pfizer Inc.
- UEI
- MHBQULRMEEJ5
- CAGE
- 86491
- Vendor location
- New York, NY
- Contract
- 75D30124D19082
- Obligated
- $3,298,698.20, potential $118,195,000
- Actions
- 7 between June 27, 2024 and November 21, 2025
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
- Recipient
- Sanofi Vaccines US Inc.
- UEI
- NCXBGGQ8YTU9
- CAGE
- 7V915
- Vendor location
- Swiftwater, PA
- Contract
- 75D30124D19083
- Obligated
- $2,368,734.03, potential $54,975,838
- Actions
- 8 between June 27, 2024 and December 30, 2025
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
- Recipient
- Vbi Vaccines (Delaware) Inc.
- UEI
- FKYXJCJ2BKC3
- CAGE
- 7SE98
- Vendor location
- Cambridge, MA
- Contract
- 75D30124D19084
- Obligated
- $0.00, potential $0
- Actions
- 3 between June 26, 2024 and February 12, 2026
- Competition
- Full and Open Competition, 8 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 2024 Adult Vaccines
- Match
- solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- William O'Bryanrvq0@cdc.gov